104 related articles for article (PubMed ID: 1187555)
1. [Drug therapy of minimal brain dysfunction syndrome (clinical study using Captagon)].
Mangold B
Prax Kinderpsychol Kinderpsychiatr; 1975 Jul; 24(5):185-90. PubMed ID: 1187555
[No Abstract] [Full Text] [Related]
2. [Clinical picture, diagnosis and treatment possibilities of minimal brain dysfunction].
Peters H; Vogt HJ
Offentl Gesundheitswes; 1988; 50(8-9):480-4. PubMed ID: 2972964
[No Abstract] [Full Text] [Related]
3. [Treatment of attention deficit disorders in adulthood using psychostimulants and low-dose neuroleptics--a critical case report].
Schmidt LG; Schlünder M; Reischies FM
Psychiatr Prax; 1988 Mar; 15(2):62-5. PubMed ID: 2898788
[TBL] [Abstract][Full Text] [Related]
4. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
[TBL] [Abstract][Full Text] [Related]
5. [The minimal brain dysfunction syndrome].
Verret S
Vie Med Can Fr; 1973 Jul; 2(7):649-55. PubMed ID: 4760948
[No Abstract] [Full Text] [Related]
6. Fenetylline: therapeutic use, misuse and/or abuse.
Kristen G; Schaefer A; von Schlichtegroll A
Drug Alcohol Depend; 1986 Jun; 17(2-3):259-71. PubMed ID: 3743408
[TBL] [Abstract][Full Text] [Related]
7. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
8. NTP-CERHR monograph on the potential human reproductive and developmental effects of amphetamines.
National Toxicology Program
NTP CERHR MON; 2005 Jul; (16):vii-III1. PubMed ID: 16130031
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of hyperactivity and attention deficit with amphetamine. Experience with five adult prisoners].
Stovner AM; Wyller TB; Skulberg A; Os L; Korsmo G
Tidsskr Nor Laegeforen; 1996 Jun; 116(17):2002-5. PubMed ID: 8766640
[TBL] [Abstract][Full Text] [Related]
10. [Amphetamine in the therapy of hyperactivity in children].
Scholander T
Lakartidningen; 1982 Dec; 79(50):4759-61. PubMed ID: 7154786
[No Abstract] [Full Text] [Related]
11. [Minimal cerebral dysfunction. Apropos of the treatment of 90 cases].
Vildoso de Palacios E
Rev Neuropsiquiatr; 1971 Dec; 34(4):301-8. PubMed ID: 5164564
[No Abstract] [Full Text] [Related]
12. [Urine levels of fenethylline and amphetamine after administration of Captagon].
Iffland R
Arch Kriminol; 1982; 169(3-4):81-8. PubMed ID: 7082126
[TBL] [Abstract][Full Text] [Related]
13. Minimal brain dysfunctions in children.
Peters JE
Am Fam Physician; 1974 Jul; 10(1):115-23. PubMed ID: 4834966
[No Abstract] [Full Text] [Related]
14. Attention-deficit-hyperactivity disorder: an update.
Dopheide JA; Pliszka SR
Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
[TBL] [Abstract][Full Text] [Related]
15. [Drug therapy of early-childhood minimal brain damage].
Zueblin W
Bull Schweiz Akad Med Wiss; 1976 Jul; 32(1-3):141-6. PubMed ID: 990576
[TBL] [Abstract][Full Text] [Related]
16. [Hyperkinetic syndrome in childhood and adolescence. Diagnosis and therapy].
Schulz E; Remschmidt H
Med Monatsschr Pharm; 1991 May; 14(5):137-48. PubMed ID: 1857319
[No Abstract] [Full Text] [Related]
17. [Minimal brain dysfunction syndrome in children].
Karkowski M
Wiad Lek; 1984 Oct; 37(20):1605-10. PubMed ID: 6396962
[No Abstract] [Full Text] [Related]
18. The hyperactive child.
Muiva PM
East Afr Med J; 1979 May; 56(5):237-40. PubMed ID: 467294
[No Abstract] [Full Text] [Related]
19. Adderall XR: long acting stimulant for single daily dosing.
Sallee FR; Smirnoff AV
Expert Rev Neurother; 2004 Nov; 4(6):927-34. PubMed ID: 15853519
[TBL] [Abstract][Full Text] [Related]
20. Fenfluramine treatment of childhood attention deficit disorder with hyperactivity: a preliminary report.
Donnelly M; Rapoport JL; Ismond DR
Psychopharmacol Bull; 1986; 22(1):152-4. PubMed ID: 3523573
[No Abstract] [Full Text] [Related]
[Next] [New Search]
